AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
AIBOTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.00+0.00 (+42.86%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0007 (−18.92%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
AIBOTICS, INC. saw revenue fall 100.0% to $0 over the twelve months to Jun 30, 2026.
Revenue
$0
-100.0% vs. a year earlier
Operating income
-$1.73M
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $0
- Net income
- -$2.09M
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
$0-100.0% YoY
Gross profit
$0-100.0% YoY
Operating income
-$1.73M
Net income
-$2.09M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months